Condition
Nasal Polyps
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
18 shownMoving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal PolypsNCT05009758 · 2021-09-01
RECRUITINGStudy of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid SprayNCT06461949 · 2024-07-17
WITHDRAWNMechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory DiseaseNCT05575037 · 2023-08-01
ACTIVE_NOT_RECRUITINGAssessment of Oral and Nasal Breathing With Sensors Analyzing AlgorithmNCT05869071 · 2023-05-23
UNKNOWNEfficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal PolypsNCT05274750 · 2022-04-22
COMPLETEDEfficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2)NCT05281523 · 2022-04-18
COMPLETEDRANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.NCT05180357 · 2021-11-23
COMPLETEDNovel Inflammatory Markers in Different Phenotypes of Severe AsthmaNCT04888910 · 2021-03-01
UNKNOWNNO Measurements in Screening for Asthma and OSA, in Patients With CRSwNPNCT03963648 · 2019-09-13
UNKNOWNStudy of Efficacy of Fevipiprant in Patients With Nasal Polyposis and AsthmaNCT03681093 · 2019-03-26
COMPLETEDGenetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)NCT04261582 · 2018-11-06
SUSPENDEDAggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)NCT03704415 · 2018-10-23
COMPLETEDAsthma With Nasal PolyposisNCT03694847 · 2018-07-19
COMPLETEDTherapeutic Control of Aspirin-Exacerbated Respiratory Disease With IfetrobanNCT03326063 · 2018-04-26
COMPLETEDStudy of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With ReslizumabNCT03369574 · 2017-11-14
WITHDRAWNATP Project (Asthma afTer Polypectomy)NCT02427503 · 2016-07-01
COMPLETEDComparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus SurgeryNCT02110654 · 2014-06-01
COMPLETEDBiopsies and PolypsNCT00835445 · 2007-07-01
COMPLETEDCommon interventions
PlaceboDRUG4Depemokimab (GSK3511294)BIOLOGICAL2DupilumabDRUG2Asthma with NP and require surgeryPROCEDURE1Blood samplingPROCEDURE1Body plethysmographDEVICE1BronchoscopyPROCEDURE1Extended endoscopic sinus surgeryPROCEDURE1FASENRA(benralizumab)OTHER1FeNOPROCEDURE1Fevipiprant 150 mgDRUG1Fevipiprant 450 mgDRUG1Fractioned Exhaled Nitrogen Oxide measurementsDIAGNOSTIC_TEST1IfetrobanDRUG1Limited endoscopic sinus surgeryPROCEDURE1Lung X-RayPROCEDURE1Medical history of patients, demographic data, concomitant medication, questionnaireOTHER1mometasone furoate nasal sprayDRUG1MontelukastDRUG1Nasal biopsyPROCEDURE1Nasal mucosa mRNA samplingPROCEDURE1Nasal samplingPROCEDURE1NasosorptionPROCEDURE1observationalOTHER1Oral samplingPROCEDURE1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Brigham and Women's Hospital
2
GlaxoSmithKline
2
AstraZeneca
1
Christian von Buchwald
1
First Affiliated Hospital, Sun Yat-Sen University
1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
1
Helsinki University Central Hospital
1
Laval University
1
Louis-Philippe Boulet
1
Medical University of Vienna
1
National Institute on Deafness and Other Communication Disorders (NIDCD)
1
National Jewish Health
1
Novartis Pharmaceuticals
1
Oulu University Hospital
1
University of Pisa
1
Trial status mix
COMPLETED10
UNKNOWN3
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
RECRUITING1
SUSPENDED1
Phase mix
PHASE34
NA3
PHASE22
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.